Neogenomics (NEO) Capital Leases (2010 - 2021)

Neogenomics has reported Capital Leases for 12 years, with the latest figure at $71000.0 in Q4 2021.

• For the quarter ending Q4 2021, Capital Leases fell 92.66% year-over-year to $71000.0; the trailing twelve-month figure through Dec 2021 stood at $71000.0 (down 92.66% YoY), and the FY2021 full-year result was $71000.0, down 92.66% from the prior year.
• Capital Leases for Q4 2021 stood at $71000.0, down from $152000.0 in the prior quarter.
• The five-year high for Capital Leases was $11.5 million in Q4 2018, with the low at $71000.0 in Q4 2021.
• Historically, Capital Leases has averaged $4.1 million across 5 years, with a median of $4.3 million in 2017.
• Annual changes were most pronounced in 2017 — Capital Leases soared 96.02% — and 2021, when it plunged 92.66%.
• Neogenomics' Capital Leases stood at $10.5 million in 2017, then rose by 9.54% to $11.5 million in 2018, then slumped by 72.3% to $3.2 million in 2019, then plunged by 69.77% to $967000.0 in 2020, then sank by 92.66% to $71000.0 in 2021.
• The last three Capital Leases figures came in at $71000.0 (Q4 2021), $152000.0 (Q3 2021), and $448000.0 (Q2 2021), per Business Quant data.